TITLE

Moxifloxacin--acetaminophen--warfarin interaction during bacille Calmette-Guérin treatment for bladder cancer

AUTHOR(S)
Lee, Roy; Wen, Alice; Berube, Caroline
PUB. DATE
May 2011
SOURCE
American Journal of Health-System Pharmacy;5/1/2011, Vol. 68 Issue 9, p814
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose. The case of a patient receiving long-term anticoagulation with warfarin who had supratherapeutic International Normalized Ratios (INRs) after receiving concomitant acetaminophen and moxifloxacin as prophylaxis with bacille Calmette-Guérin (BCG) therapy for bladder cancer is reported. Summary. An 89-year-old man receiving long-term anticoagulation with warfarin sodium (total weekly dosage of 19 mg) arrived at the anticoagulation clinic for his monthly visit. On the day before this visit, he had received the third of six serial weekly BCG bladder instillations for the treatment of bladder cancer. He did not report that acetaminophen 1000 mg four times daily and one dose of moxifloxacin 400 mg had been prescribed before these instillations. An INR check revealed a value of 6.7. He was instructed to take 2.5 mg of oral phytonadione and to withhold his warfarin dose that night. On the next day, his INR was 3.2. Each time he arrived at the anticoagulation clinic after his BCG therapy, his INR was supratherapeutic, except after his fourth treatment (INR of 2.5), which can be explained by residual effects from the phytonadione he received a week earlier. After completion of his BCG therapy, he was instructed to resume his usual warfarin sodium dosage of 19 mg weekly, and his INR remained in the desired therapeutic range. According to the Drug Interaction Probability Scale, the development of supratherapeutic INRs was probably associated with concomitant acetaminophen and moxifloxacin use. Conclusion. An 89-year-old man receiving long-term anticoagulation with warfarin had supratherapeutic INRs after receiving acetaminophen and moxifloxacin as prophylaxis during BCG therapy for bladder cancer.
ACCESSION #
60335109

 

Related Articles

  • OF SPECIAL INTEREST.  // American Journal of Health-System Pharmacy;9/1/2011, Vol. 68 Issue 17, p1563 

    The article presents clinical updates. The necessity of providing high dosages to treat troublesome pathogens is discussed as standard dosages of antimicrobials fail to provide optimal bactericidal activity against Pseudomonas aeruginosa. A study shows that using warfarin and concomitant...

  • Dabigatran etexilate: a guide to its use in the prevention of thromboembolic disorders.  // Drugs & Therapy Perspectives;Jun2011, Vol. 27 Issue 6, p1 

    Dabigatran etexilate, a new approach to the inhibition of thrombin, provides an effective and useful addition to the therapeutic options available to prevent stroke and systemic embolism in adults with non-valvular atrial fibrillation, and venous thromboembolic events in patients undergoing...

  • Standardizing the prothrombin time: Calibrating coagulation instruments as well as thromboplastin.  // JAMA: Journal of the American Medical Association;9/8/93, Vol. 270 Issue 10, p1184 

    Presents an abstract on the comparison of prothrombin time and international normalized ratio. Warfarin dose; High correlation; Instrumentation effect; Need for calibration of coagulation instruments and thromboplastins to standardize warfarin therapy; Publication by Daniel M. Becker et al. in...

  • Probable interaction between warfarin and bee pollen. Hurren, Kathryn M.; Lewis, Carrie L. // American Journal of Health-System Pharmacy;12/1/2010, Vol. 67 Issue 23, p2034 

    Purpose. A probable interaction between warfarin and honeybee-collected pollen is reported. Summary. A 71-year-old Caucasian man arrived at an anticoagulation clinic for routine warfarin monitoring with an International Normalized Ratio (INR) value of 7.1 (therapeutic range, 2.0-3.0). His...

  • A survey: Precepts and practices in drug use indicators at Government Healthcare Facilities: A Hospital-based prospective analysis. Menik, Hettihewa L.; Isuru, Amrasinghe I.; Sewwandi, Subasinghe // Journal of Pharmacy & Bioallied Sciences;Jan-Mar2011, Vol. 3 Issue 1, p165 

    Background: We planned to identify the difficulties in practicing the rational use of medicine in health facilities, using drug-use indicators. Materials and Methods: We studied the average consultation time (ACT), average number of drugs per encounter (ANDE), percentage of drugs by generic name...

  • BARRIERS AFFECTING COMPLIANCE OF PATIENTS WITH CHRONIC DISEASES : A PRELIMINARY STUDY IN UNITED ARAB EMIRATES (UAE) POPULATION. IBRAHIM, OSAMA H. MOHAMED; JIRJEES, FERAS JASSIM; MAHDI, HALA JEHAD // Asian Journal of Pharmaceutical & Clinical Research;Apr2011 Supplement, p42 

    Medication non-compliance is an ignored health problem in developing countries, which have an alarming average of less than 50% of patients complying with medication instructions. Such non-compliance is considered a major challenge to effective management of most chronic diseases such as...

  • Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial. Zhang, Qian; Bal-dit-Sollier, Claire; Drouet, Ludovic; Simoneau, Guy; Alvarez, Jean-Claude; Pruvot, Sandrine; Aubourg, Romain; Berge, Natacha; Bergmann, Jean-Francois; Mouly, Stéphane; Mahé, Isabelle // European Journal of Clinical Pharmacology;Mar2011, Vol. 67 Issue 3, p309 

    Purpose: We investigated whether acetaminophen, given at 2 g/day and 3 g/day might potentiate the anticoagulant effect of warfarin. Methods: Forty-five patients on stable warfarin therapy, enrolled in this prospective, randomized, parallel (three arms), placebo-controlled study, received a...

  • Warfarin Interactions with Antimicrobial Agents: Part I. Aung, Gregory; Leung, Crystal; Kawamoto, Laura; Song, Jessica C. // Infectious Disease Alert;Apr2010, Vol. 29 Issue 7, p75 

    The article focuses on a study on the interactions of warfarin with antimicrobial agents. It notes that the study aims to increase the awareness among clinicians over the potential interactions between the drugs in a bid to prevent and manage supratherapeutic and subtherapeutic international...

  • The Risk of Overanticoagulation with Antibiotic Use in Outpatients on Stable Warfarin Regimens. Glasheen, Jeffrey J.; Fugit, Randolph V.; Prochazka, Allan V. // JGIM: Journal of General Internal Medicine;Jul2005, Vol. 20 Issue 7, p653 

    Medication interactions account for a significant proportion of overanticoagulation in warfarin users. However, little is known about the incidence or degree of interaction with commonly used oral antibiotics. To investigate the incidence and degree of overanticoagulation associated with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics